Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.
In recent years, Solilis Asia Pacific market has developed rapidly. However, with the development of the economic situation in the Asia-Pacific region, other companies have entered the industry one after another; prices will decline in the next five years.Soliris is widely used in patients such as PNH and aHUS. PNH patients have the highest proportion of Soliris.Japan is the world's largest consumer market, and China is the second largest consumer market after Japan.Market competition is not intense. Soliris (eculizumab) is the first and only drug approved for the treatment of patients with paroxysmal nocturnal hemoglobinuria (PNH) or atypical hemolytic uremic syndrome (aHUS). PNH and aHUS It is caused by long-term uncontrolled activation of the complement component of the immune system.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Soliris (Eculizumab) market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Soliris (Eculizumab) market. Detailed analysis of key players, along with key growth strategies adopted by Soliris (Eculizumab) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Alexion
By Type:
Plasma Exchange
Plasma Infusion
By End-User:
PNH
AHUS
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Soliris (Eculizumab) Market
-
1.3 Market Segment by Type
-
1.3.1 USA Soliris (Eculizumab) Market Size and Growth Rate of Plasma Exchange from 2016 to 2027
-
1.3.2 USA Soliris (Eculizumab) Market Size and Growth Rate of Plasma Infusion from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Soliris (Eculizumab) Market Size and Growth Rate of PNH from 2016 to 2027
-
1.4.2 USA Soliris (Eculizumab) Market Size and Growth Rate of AHUS from 2016 to 2027
-
1.4.3 USA Soliris (Eculizumab) Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Soliris (Eculizumab) Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Soliris (Eculizumab) Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Soliris (Eculizumab) Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Soliris (Eculizumab) Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Soliris (Eculizumab) Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Soliris (Eculizumab) by Major Types
-
3.4.1 Market Size and Growth Rate of Plasma Exchange
-
3.4.2 Market Size and Growth Rate of Plasma Infusion
4 Segmentation of Soliris (Eculizumab) Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Soliris (Eculizumab) by Major End-Users
-
4.4.1 Market Size and Growth Rate of Soliris (Eculizumab) in PNH
-
4.4.2 Market Size and Growth Rate of Soliris (Eculizumab) in AHUS
-
4.4.3 Market Size and Growth Rate of Soliris (Eculizumab) in Others
5 Market Analysis by Regions
-
5.1 USA Soliris (Eculizumab) Production Analysis by Regions
-
5.2 USA Soliris (Eculizumab) Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Soliris (Eculizumab) Landscape Analysis
-
6.1 West USA Soliris (Eculizumab) Landscape Analysis by Major Types
-
6.2 West USA Soliris (Eculizumab) Landscape Analysis by Major End-Users
7 South USA Soliris (Eculizumab) Landscape Analysis
-
7.1 South USA Soliris (Eculizumab) Landscape Analysis by Major Types
-
7.2 South USA Soliris (Eculizumab) Landscape Analysis by Major End-Users
8 Middle West USA Soliris (Eculizumab) Landscape Analysis
-
8.1 Middle West USA Soliris (Eculizumab) Landscape Analysis by Major Types
-
8.2 Middle West USA Soliris (Eculizumab) Landscape Analysis by Major End-Users
9 Northeast USA Soliris (Eculizumab) Landscape Analysis
-
9.1 Northeast USA Soliris (Eculizumab) Landscape Analysis by Major Types
-
9.2 Northeast USA Soliris (Eculizumab) Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Alexion
-
10.1.1 Alexion Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Soliris (Eculizumab) Market Size and Growth Rate of Plasma Exchange from 2016 to 2027
-
Figure USA Soliris (Eculizumab) Market Size and Growth Rate of Plasma Infusion from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Soliris (Eculizumab) Market Size and Growth Rate of PNH from 2016 to 2027
-
Figure USA Soliris (Eculizumab) Market Size and Growth Rate of AHUS from 2016 to 2027
-
Figure USA Soliris (Eculizumab) Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Soliris (Eculizumab) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Soliris (Eculizumab) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Soliris (Eculizumab) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Soliris (Eculizumab) Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Soliris (Eculizumab) Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Soliris (Eculizumab)
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Soliris (Eculizumab) by Different Types from 2016 to 2027
-
Table Consumption Share of Soliris (Eculizumab) by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Plasma Exchange
-
Figure Market Size and Growth Rate of Plasma Infusion
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Soliris (Eculizumab) by Different End-Users from 2016 to 2027
-
Table Consumption Share of Soliris (Eculizumab) by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of PNH
-
Figure Market Size and Growth Rate of AHUS
-
Figure Market Size and Growth Rate of Others
-
Table USA Soliris (Eculizumab) Production by Regions
-
Table USA Soliris (Eculizumab) Production Share by Regions
-
Figure USA Soliris (Eculizumab) Production Share by Regions in 2016
-
Figure USA Soliris (Eculizumab) Production Share by Regions in 2021
-
Figure USA Soliris (Eculizumab) Production Share by Regions in 2027
-
Table USA Soliris (Eculizumab) Consumption by Regions
-
Table USA Soliris (Eculizumab) Consumption Share by Regions
-
Figure USA Soliris (Eculizumab) Consumption Share by Regions in 2016
-
Figure USA Soliris (Eculizumab) Consumption Share by Regions in 2021
-
Figure USA Soliris (Eculizumab) Consumption Share by Regions in 2027
-
Table West USA Soliris (Eculizumab) Consumption by Types from 2016 to 2027
-
Table West USA Soliris (Eculizumab) Consumption Share by Types from 2016 to 2027
-
Figure West USA Soliris (Eculizumab) Consumption Share by Types in 2016
-
Figure West USA Soliris (Eculizumab) Consumption Share by Types in 2021
-
Figure West USA Soliris (Eculizumab) Consumption Share by Types in 2027
-
Table West USA Soliris (Eculizumab) Consumption by End-Users from 2016 to 2027
-
Table West USA Soliris (Eculizumab) Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Soliris (Eculizumab) Consumption Share by End-Users in 2016
-
Figure West USA Soliris (Eculizumab) Consumption Share by End-Users in 2021
-
Figure West USA Soliris (Eculizumab) Consumption Share by End-Users in 2027
-
Table South USA Soliris (Eculizumab) Consumption by Types from 2016 to 2027
-
Table South USA Soliris (Eculizumab) Consumption Share by Types from 2016 to 2027
-
Figure South USA Soliris (Eculizumab) Consumption Share by Types in 2016
-
Figure South USA Soliris (Eculizumab) Consumption Share by Types in 2021
-
Figure South USA Soliris (Eculizumab) Consumption Share by Types in 2027
-
Table South USA Soliris (Eculizumab) Consumption by End-Users from 2016 to 2027
-
Table South USA Soliris (Eculizumab) Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Soliris (Eculizumab) Consumption Share by End-Users in 2016
-
Figure South USA Soliris (Eculizumab) Consumption Share by End-Users in 2021
-
Figure South USA Soliris (Eculizumab) Consumption Share by End-Users in 2027
-
Table Middle West USA Soliris (Eculizumab) Consumption by Types from 2016 to 2027
-
Table Middle West USA Soliris (Eculizumab) Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Soliris (Eculizumab) Consumption Share by Types in 2016
-
Figure Middle West USA Soliris (Eculizumab) Consumption Share by Types in 2021
-
Figure Middle West USA Soliris (Eculizumab) Consumption Share by Types in 2027
-
Table Middle West USA Soliris (Eculizumab) Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Soliris (Eculizumab) Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Soliris (Eculizumab) Consumption Share by End-Users in 2016
-
Figure Middle West USA Soliris (Eculizumab) Consumption Share by End-Users in 2021
-
Figure Middle West USA Soliris (Eculizumab) Consumption Share by End-Users in 2027
-
Table Northeast USA Soliris (Eculizumab) Consumption by Types from 2016 to 2027
-
Table Northeast USA Soliris (Eculizumab) Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Soliris (Eculizumab) Consumption Share by Types in 2016
-
Figure Northeast USA Soliris (Eculizumab) Consumption Share by Types in 2021
-
Figure Northeast USA Soliris (Eculizumab) Consumption Share by Types in 2027
-
Table Northeast USA Soliris (Eculizumab) Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Soliris (Eculizumab) Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Soliris (Eculizumab) Consumption Share by End-Users in 2016
-
Figure Northeast USA Soliris (Eculizumab) Consumption Share by End-Users in 2021
-
Figure Northeast USA Soliris (Eculizumab) Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Alexion
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alexion
-
Figure Sales and Growth Rate Analysis of Alexion
-
Figure Revenue and Market Share Analysis of Alexion
-
Table Product and Service Introduction of Alexion
-
